Bausch Health Companies Inc. Announces Second-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bausch Health Companies (BHC) PT Raised to $26 at RBC Capital
August 8, 2018 8:12 AM EDTRBC Capital raised its price target on Bausch Health Companies (NYSE: BHC) to $26.00 (from $25.00) while maintaining a Sector Perform rating.
... MoreBausch Health Companies (BHC) PT Raised to $30 at Deutsche Bank
August 8, 2018 6:32 AM EDTDeutsche Bank raised its price target on Bausch Health Companies (NYSE: BHC) to $30.00 (from $25.00) while maintaining a Buy rating.
Analsyt Gregg Gilbert commented, "BHC reported solid 2Q18 results, with revenue, EBITDA, and EPS coming in above our model (cash flow from ops... More
Bausch Health Companies (BHC) Reports Q2 Revenues of $2.125B; Boosts FY18 Adj. EBITDA Guidance, Offers FY18 Revenue Outlook
August 7, 2018 7:23 AM EDTBausch Health Companies (NYSE: BHC) reported Q2 revenue for the quarter came in at $2.13 billion.
Revenues of $2.128 BillionGAAP Net Loss of $873 MillionGAAP Cash Flow from Operations of $222 MillionAdjusted EBITDA (non-GAAP)1 of $868 MillionDelivered Second Consecutive Quarter of Overall Organic Revenue Growth2, Driven by the Salix... More